SE0100478A
SE0100478D0
(en)
|
2001-02-13 |
2001-02-13 |
Novel formulation
|
NZ526994A
NZ526994A
(en)
|
2001-02-13 |
2002-02-08 |
Novel modified released formulation
|
IL15707502A
IL157075A0
(en)
|
2001-02-13 |
2002-02-08 |
Novel modified release formulation
|
ES02710645T
ES2261643T3
(en)
|
2001-02-13 |
2002-02-08 |
NEW FORMULATION OF MODIFIED LIBERATION.
|
MXPA03007092A
MXPA03007092A
(en)
|
2001-02-13 |
2002-02-08 |
Novel modified released formulation.
|
CNA028049144A
CN1491104A
(en)
|
2001-02-13 |
2002-02-08 |
Novel modified release formulation
|
DK02710645T
DK1368006T3
(en)
|
2001-02-13 |
2002-02-08 |
Hitherto modified release formulation
|
PT02710645T
PT1368006E
(en)
|
2001-02-13 |
2002-02-08 |
NEW MODIFIED LIBERTACAO FORMULA
|
PCT/SE2002/000228
WO2002064121A1
(en)
|
2001-02-13 |
2002-02-08 |
Novel modified released formulation
|
EP02710645A
EP1368006B1
(en)
|
2001-02-13 |
2002-02-08 |
Novel modified released formulation
|
CNA028049063A
CN1491105A
(en)
|
2001-02-13 |
2002-02-08 |
Novel modified released formulation
|
JP2002563916A
JP2004518709A
(en)
|
2001-02-13 |
2002-02-08 |
New modified release formulation
|
BR0206825-7A
BR0206825A
(en)
|
2001-02-13 |
2002-02-08 |
Modified multiparticulate solid release dispersion formulation, process for preparing the formulation, using it, tableting, and methods for treating cardiovascular disease, and for treating cancer
|
CA002434835A
CA2434835A1
(en)
|
2001-02-13 |
2002-02-08 |
Novel modified released formulation
|
JP2002563914A
JP2004518708A
(en)
|
2001-02-13 |
2002-02-08 |
New formulations with improved release
|
SI200230343T
SI1368006T1
(en)
|
2001-02-13 |
2002-02-08 |
Novel modified released formulation
|
DE60211130T
DE60211130T2
(en)
|
2001-02-13 |
2002-02-08 |
NEW FORMULATION WITH MODIFIED RELEASE
|
KR10-2003-7010577A
KR20040058103A
(en)
|
2001-02-13 |
2002-02-08 |
Novel Modified Release Formulation
|
NZ526993A
NZ526993A
(en)
|
2001-02-13 |
2002-02-08 |
Pharmaceutical formulation of a drug substance that has a pH-dependent solubility in water
|
AT02710645T
ATE324871T1
(en)
|
2001-02-13 |
2002-02-08 |
NEW MODIFIED RELEASE FORMULATION
|
EP02711597A
EP1361868A1
(en)
|
2001-02-13 |
2002-02-08 |
Novel modified release formulation
|
PCT/SE2002/000227
WO2002064118A1
(en)
|
2001-02-13 |
2002-02-08 |
Novel modified release formulation
|
CA002434542A
CA2434542A1
(en)
|
2001-02-13 |
2002-02-08 |
Novel modified release formulation
|
US10/467,900
US20040067256A1
(en)
|
2001-02-13 |
2002-02-08 |
Novel modified release formulation
|
US10/467,723
US20040067252A1
(en)
|
2001-02-13 |
2002-02-08 |
Novel modified release formulation
|
AU2002228579A
AU2002228579B2
(en)
|
2001-02-13 |
2002-02-08 |
Novel modified released formulation
|
ZA200305944A
ZA200305944B
(en)
|
2001-02-13 |
2003-07-31 |
Novel modified release formulation.
|
NO20033564A
NO20033564L
(en)
|
2001-02-13 |
2003-08-12 |
New formulation with modified release effect
|
HK04102657A
HK1059740A1
(en)
|
2001-02-13 |
2004-04-15 |
Novel modified released formulation
|
US11/748,366
US20080118560A1
(en)
|
2001-02-13 |
2007-05-14 |
Novel modified release formulation
|